Skip to main content
Premium Trial:

Request an Annual Quote

Biocartis, Philips, WTSI Collaborate on Cancer MDx Technology

NEW YORK (GenomeWeb News) – Biocartis today announced it is developing a workflow for extracting, amplifying, and detecting tumor DNA on its diagnostic platforms in collaboration with the Wellcome Trust Sanger Institute and Philips Research.

The test, the Swiss molecular diagnostics firm said, could lead to better clinical care and improved quality of life for patients by enabling drugs to be targeted specifically to those patients who demonstrate meaningful response to the drugs.

Under the terms of the deal, Biocartis retains its full IP rights and will have access to IP resulting from the collaboration. Financial and other terms were not disclosed.

The system under development will use disposable, microfluidic cartridges with digitally encoded microparticles for the detection of multiple DNA samples, Patrick van den Bogaard, director of life science research at Biocartis, said.

"The test aims to be highly specific and sensitive, being able to isolate and detect just a few molecules of tumor DNA per [milliliter] of blood. To implement such tests in a real-world healthcare system requires development of fully automated, high multiplexing diagnostic instruments and technology which is the core focus of Biocartis," van den Bogaard said in a statement.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.